Ebi3 Binding to IFN-γ and IL-10 Limits Their Function
The Journal of Immunology · 15.10.2024 · 213 (8) · 1115-1124
DOI: 10.4049/jimmunol.2400236 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 06.09.2024. Verfasst von Ellen N Scott und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA. Hauptthemen laut MEDLINE: Minor Histocompatibility Antigens, Interferon-gamma, Interleukin-10. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
EBV-induced gene 3 (Ebi3) is a β subunit within the IL-12 cytokine family that canonically binds to α subunits p19, p28, or p35 to form the heterodimeric cytokines IL-39, IL-27, and IL-35, respectively. In the last decade, the binding partners for Ebi3 have continued to expand to include IL-6 and the other IL-12 family β subunit p40, revealing the possibility that Ebi3 may be able to bind to other cytokines and have distinct functions. We first explored this possibility utilizing an in vivo mouse model of regulatory T cell–restricted deletions of the subunits composing the cytokine IL-35, p35, and Ebi3, and we observed a differential impact on CD8+ T cell inhibitory receptor expression despite comparable reduction in tumor growth. We then screened the ability of Ebi3 to bind to different cytokines with varying structural resemblance to the IL-12 family α subunits. These in vitro screens revealed extracellular binding of Ebi3 to both IFN-γ and IL-10. Ebi3 bound to IFN-γ and IL-10 abrogated signal transduction and downstream functions of both cytokines. Lastly, we validated that extracellular complex formation after mixing native proteins resulted in loss of function. These data suggest that secreted partnerless Ebi3 may bind to cytokines within the extracellular microenvironment and act as a cytokine sink, further expanding the potential immunological impact of Ebi3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
- Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
- Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA.
- Friedman Center for Nutrition and Inflammation, Weill Cornell Medicine, Cornell University, New York, NY.
- Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY.
- Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA.
ORCID-Profile: Hiroshi Yano, Creg J Workman, Dario A A Vignali
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Scott, E. N., Ye, C., Yano, H., Lipatova, Z., Brunazzi, E., Vignali, K. M., Workman, C. J., & Vignali, D. A. A. (2024). Ebi3 Binding to IFN-γ and IL-10 Limits Their Function. The Journal of Immunology, 213(8), 1115-1124. https://doi.org/10.4049/jimmunol.2400236
Vancouver
Scott EN, Ye C, Yano H, Lipatova Z, Brunazzi E, Vignali KM, et al. Ebi3 Binding to IFN-γ and IL-10 Limits Their Function. The Journal of Immunology. 2024;213(8):1115-1124. doi:10.4049/jimmunol.2400236
BibTeX
@article{Scott2024,
author = {Scott, Ellen N and Ye, Cheng and Yano, Hiroshi and Lipatova, Zhanna and Brunazzi, Erin and Vignali, Kate M and Workman, Creg J and Vignali, Dario A A},
title = {Ebi3 Binding to IFN-γ and IL-10 Limits Their Function},
journal = {The Journal of Immunology},
year = {2024},
volume = {213},
number = {8},
pages = {1115--1124},
doi = {10.4049/jimmunol.2400236}
}
EUVIMED